These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25579511)

  • 21. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
    Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
    J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer.
    Crumley AB; Stuart RC; McKernan M; McDonald AC; McMillan DC
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e325-9. PubMed ID: 17645468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer.
    Gioulbasanis I; Pallis A; Vlachostergios PJ; Xyrafas A; Giannousi Z; Perdikouri IE; Makridou M; Kakalou D; Georgoulias V
    Lung Cancer; 2012 Aug; 77(2):383-8. PubMed ID: 22551892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
    Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G
    Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis.
    Kim MR; Kim AS; Choi HI; Jung JH; Park JY; Ko HJ
    PLoS One; 2020; 15(7):e0236445. PubMed ID: 32716955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.
    Jeong JH; Lim SM; Yun JY; Rhee GW; Lim JY; Cho JY; Kim YR
    Oncology; 2012; 83(5):292-9. PubMed ID: 22964877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study.
    Shafique K; Proctor MJ; McMillan DC; Qureshi K; Leung H; Morrison DS
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):195-201. PubMed ID: 22343838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
    Roncolato FT; Berton-Rigaud D; O'Connell R; Lanceley A; Sehouli J; Buizen L; Okamoto A; Aotani E; Lorusso D; Donnellan P; Oza A; Avall-Lundqvist E; Berek J; Hilpert F; Ledermann JA; Kaminsky MC; Stockler MR; King MT; Friedlander M
    Gynecol Oncol; 2018 Jan; 148(1):36-41. PubMed ID: 29107348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The application of the Glasgow prognostic score to predict the survival in patients with metastatic pancreatic carcinoma.
    Mohammed AA; Al-Zahrani O; Elsayed FM
    Indian J Palliat Care; 2022; 28(4):406-412. PubMed ID: 36447500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
    He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
    Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
    Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
    Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma.
    Nozoe T; Iguchi T; Egashira A; Adachi E; Matsukuma A; Ezaki T
    Am J Surg; 2011 Feb; 201(2):186-91. PubMed ID: 20832047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Modified Glasgow Prognostic Score in Advanced Cancer Patients Receiving Palliative Care.
    Pantano Nde P; Paiva BS; Hui D; Paiva CE
    J Pain Symptom Manage; 2016 Feb; 51(2):270-7. PubMed ID: 26598040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer.
    Nakayama M; Tabuchi K; Hara A
    Head Neck; 2015 Dec; 37(12):1745-9. PubMed ID: 24989115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applicability of modified Glasgow Prognostic Score in the assessment of elderly patients with cancer: A pilot study.
    Lealdini V; Trufelli DC; da Silva FB; Normando SR; Camargo EW; Matos LL; Fonseca FL; Santi PX; Del Giglio A
    J Geriatr Oncol; 2015 Nov; 6(6):479-83. PubMed ID: 26439755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostication in advanced cancer: a study examining an inflammation-based score.
    Partridge M; Fallon M; Bray C; McMillan D; Brown D; Laird B
    J Pain Symptom Manage; 2012 Aug; 44(2):161-7. PubMed ID: 22732417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic efficacy of preoperative mGPS, SIS and LCS in patients with gastric cancer.
    Chen YR; Chen YL; Ouyang SS; Xu HW; Li P; He LJ; Zhu SL
    Clin Chim Acta; 2020 Dec; 511():81-89. PubMed ID: 33002476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glasgow prognostic score is a useful predictive factor of outcome after palliative gastrectomy for stage IV gastric cancer.
    Mimatsu K; Oida T; Fukino N; Kano H; Kawasaki A; Kida K; Kuboi Y; Amano S
    Anticancer Res; 2014 Jun; 34(6):3131-6. PubMed ID: 24922683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.
    Proctor MJ; Horgan PG; Talwar D; Fletcher CD; Morrison DS; McMillan DC
    Cancer; 2013 Jun; 119(12):2325-32. PubMed ID: 23575969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
    Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
    Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.